Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PGC | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
mRNA | MET | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | SLC26A4 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | GZMB | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | SULT6B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | TRIM24 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | KRTAP21-3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | STRIP2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | TMEM213 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | SEC31B | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |